BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 1739289)

  • 41. Xeroderma Pigmentosum - Facts and Perspectives.
    Lehmann J; Seebode C; Martens MC; Emmert S
    Anticancer Res; 2018 Feb; 38(2):1159-1164. PubMed ID: 29374753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colony-forming ability of ultraviolet-irradiated xeroderma pigmentosum fibroblasts from different DNA repair complementation groups.
    Kraemer KH; Andrews AD; Barrett SF; Robbins JH
    Biochim Biophys Acta; 1976 Aug; 442(2):147-53. PubMed ID: 953007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for deficits in DNA repair by the response of irradiated human lymphocytes to phytohemagglutinin.
    Agarwal SS; Brown DQ; Katz EJ; Loeb LA
    Cancer Res; 1977 Oct; 37(10):3594-8. PubMed ID: 908009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose response and time course for induction of T6- DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation.
    Baadsgaard O; Cooper KD; Lisby S; Wulf HC; Wantzin GL
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):792-800. PubMed ID: 3500191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of repair of human DNA: evidence from studies of xeroderma pigmentosum.
    Robbins JH
    J Natl Cancer Inst; 1978 Sep; 61(3):645-56. PubMed ID: 278844
    [No Abstract]   [Full Text] [Related]  

  • 46. Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them.
    Itoh T; Linn S; Ono T; Yamaizumi M
    J Invest Dermatol; 2000 May; 114(5):1022-9. PubMed ID: 10771487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of epidermal Langerhans cells in NB-UVB-induced immunosuppression.
    Taguchi K; Fukunaga A; Ogura K; Nishigori C
    Kobe J Med Sci; 2013 Apr; 59(1):E1-9. PubMed ID: 23756657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sunlight damage to cellular DNA: Focus on oxidatively generated lesions.
    Schuch AP; Moreno NC; Schuch NJ; Menck CFM; Garcia CCM
    Free Radic Biol Med; 2017 Jun; 107():110-124. PubMed ID: 28109890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective Effect of Diphlorethohydroxycarmalol against Ultraviolet B Radiation-Induced DNA Damage by Inducing the Nucleotide Excision Repair System in HaCaT Human Keratinocytes.
    Piao MJ; Hewage SR; Han X; Kang KA; Kang HK; Lee NH; Hyun JW
    Mar Drugs; 2015 Sep; 13(9):5629-41. PubMed ID: 26404324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
    Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
    J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
    J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repair of 254 nm ultraviolet-induced (6-4) photoproducts: monoclonal antibody recognition and differential defects in xeroderma pigmentosum complementation groups A, D, and variant.
    Hiramoto T; Matsunaga T; Ichihashi M; Nikaido O; Fujiwara Y; Mishima Y
    J Invest Dermatol; 1989 Nov; 93(5):703-6. PubMed ID: 2794553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of topical pimecrolimus 1% on high-dose ultraviolet B-irradiated epidermal Langerhans cells.
    Yin Z; Xu J; Zhang Z; Luo D
    Int Immunopharmacol; 2012 Dec; 14(4):635-40. PubMed ID: 23079131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of UV irradiation on the human cells: mechanisms of repair in normal individuals and in individuals with xeroderma pigmentosum].
    Nuzzo-de Carli F
    Pathologica; 1975; 67(967-968):175-86. PubMed ID: 1219578
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells.
    Dunn WC; Regan JD
    Mol Pharmacol; 1979 Mar; 15(2):367-74. PubMed ID: 470933
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experimental study on dose effect relationships between ultraviolet rays and its early impairment].
    Tai SP
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):141-3. PubMed ID: 1395953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Xeroderma pigmentosum complementation group G--report of two cases.
    Norris PG; Hawk JL; Avery JA; Giannelli F
    Br J Dermatol; 1987 Jun; 116(6):861-6. PubMed ID: 3620347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of ultraviolet radiation on murine epidermal Langerhans cells: doses of ultraviolet radiation that modulate ICAM-1 (CD54) expression and inhibit Langerhans cell function cause delayed cytotoxicity in vitro.
    Tang A; Udey MC
    J Invest Dermatol; 1992 Jul; 99(1):83-9. PubMed ID: 1351507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pigmented Xerodermoid: first report of a family.
    Hofmann H; Jung EG; Schnyder UW
    Bull Cancer; 1978; 65(3):347-50. PubMed ID: 719186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel therapeutic approaches to xeroderma pigmentosum.
    Weon JL; Glass DA
    Br J Dermatol; 2019 Aug; 181(2):249-255. PubMed ID: 30265743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.